- Abstract:
-
Multiple candidate biomarkers for amyotrophic lateral sclerosis (ALS) have emerged across a range of platforms. Replication of results, however, has been absent in all but a few cases, and the range of control samples has been limited. If progress toward clinical translation is to continue, the specific biomarker needs of ALS, which differ from those of other neurodegenerative disorders, as well as the challenges inherent to longitudinal ALS biomarker cohorts, must be understood. Appropriate ...
Expand abstract - Publication status:
- Published
- Publisher:
- John Wiley and Sons Inc.
- Journal:
- Muscle and nerve
- Volume:
- 51
- Issue:
- 1
- Pages:
- 14-18
- Publication date:
- 2015-01-05
- DOI:
- EISSN:
-
1097-4598
- ISSN:
-
0148-639X
- URN:
-
uuid:d46c270f-cf58-4390-a003-be36629f0adc
- Source identifiers:
-
486157
- Local pid:
- pubs:486157
- Language:
- English
- Keywords:
- Copyright date:
- 2015
Journal article
Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record